216 related articles for article (PubMed ID: 22526517)
41. Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis.
Rajasingham R; Rolfes MA; Birkenkamp KE; Meya DB; Boulware DR
PLoS Med; 2012; 9(9):e1001316. PubMed ID: 23055838
[TBL] [Abstract][Full Text] [Related]
42. High-Dose Fluconazole Consolidation Therapy for Cryptococcal Meningitis in Sub-Saharan Africa: Much to Gain, Little to Lose.
Murphy RA; Hatlen TJ; Moosa MS
AIDS Res Hum Retroviruses; 2018 May; 34(5):399-403. PubMed ID: 29353491
[TBL] [Abstract][Full Text] [Related]
43. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
Loyse A; Burry J; Cohn J; Ford N; Chiller T; Ribeiro I; Koulla-Shiro S; Mghamba J; Ramadhani A; Nyirenda R; Aliyu SH; Wilson D; Le T; Oladele R; Lesikari S; Muzoora C; Kalata N; Temfack E; Mapoure Y; Sini V; Chanda D; Shimwela M; Lakhi S; Ngoma J; Gondwe-Chunda L; Perfect C; Shroufi A; Andrieux-Meyer I; Chan A; Schutz C; Hosseinipour M; Van der Horst C; Klausner JD; Boulware DR; Heyderman R; Lalloo D; Day J; Jarvis JN; Rodrigues M; Jaffar S; Denning D; Migone C; Doherty M; Lortholary O; Dromer F; Stack M; Molloy SF; Bicanic T; van Oosterhout J; Mwaba P; Kanyama C; Kouanfack C; Mfinanga S; Govender N; Harrison TS
Lancet Infect Dis; 2019 Apr; 19(4):e143-e147. PubMed ID: 30344084
[TBL] [Abstract][Full Text] [Related]
44. Early versus delayed antiretroviral treatment in HIV-positive people with cryptococcal meningitis.
Eshun-Wilson I; Okwen MP; Richardson M; Bicanic T
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD009012. PubMed ID: 30039850
[TBL] [Abstract][Full Text] [Related]
45. Liposomal amphotericin B for a case of intractable cryptococcal meningoencephalitis and immune reconstitution syndrome.
Sasakawa A; Yamamoto Y; Yajima K; Sakai M; Uehira T; Shirasaka T; Makie T
J Med Invest; 2008 Aug; 55(3-4):292-6. PubMed ID: 18797146
[TBL] [Abstract][Full Text] [Related]
46. Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis.
Concha-Velasco F; González-Lagos E; Seas C; Bustamante B
PLoS One; 2017; 12(3):e0174459. PubMed ID: 28355252
[TBL] [Abstract][Full Text] [Related]
47. Cryptococcal meningitis in immunocompetent children.
Yuanjie Z; Jianghan C; Nan X; Xiaojun W; Hai W; Wanqing L; Julin G
Mycoses; 2012 Mar; 55(2):168-71. PubMed ID: 21762212
[TBL] [Abstract][Full Text] [Related]
48. Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole.
Schaars CF; Meintjes GA; Morroni C; Post FA; Maartens G
BMC Infect Dis; 2006 Jul; 6():118. PubMed ID: 16846523
[TBL] [Abstract][Full Text] [Related]
49. Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.
de Gans J; Portegies P; Tiessens G; Eeftinck Schattenkerk JK; van Boxtel CJ; van Ketel RJ; Stam J
AIDS; 1992 Feb; 6(2):185-90. PubMed ID: 1313682
[TBL] [Abstract][Full Text] [Related]
50. Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.
Kartalija M; Kaye K; Tureen JH; Liu Q; Täuber MG; Elliott BR; Sande MA
J Infect Dis; 1996 May; 173(5):1216-21. PubMed ID: 8627075
[TBL] [Abstract][Full Text] [Related]
51. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
Louie A; Liu W; Miller DA; Sucke AC; Liu QF; Drusano GL; Mayers M; Miller MH
Antimicrob Agents Chemother; 1999 Dec; 43(12):2831-40. PubMed ID: 10582868
[TBL] [Abstract][Full Text] [Related]
52. Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.
Loyse A; Dromer F; Day J; Lortholary O; Harrison TS
J Antimicrob Chemother; 2013 Nov; 68(11):2435-44. PubMed ID: 23788479
[TBL] [Abstract][Full Text] [Related]
53. Treating cryptococcal meningitis in people with HIV.
BMJ; 2013 Apr; 346():f2203. PubMed ID: 23575571
[No Abstract] [Full Text] [Related]
54. Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis.
Larsen RA; Bauer M; Weiner JM; Diamond DM; Leal ME; Ding JC; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 1996 Sep; 40(9):2178-82. PubMed ID: 8878602
[TBL] [Abstract][Full Text] [Related]
55. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Powderly WG; Saag MS; Cloud GA; Robinson P; Meyer RD; Jacobson JM; Graybill JR; Sugar AM; McAuliffe VJ; Follansbee SE
N Engl J Med; 1992 Mar; 326(12):793-8. PubMed ID: 1538722
[TBL] [Abstract][Full Text] [Related]
56. Antifungal treatment for cryptococcal meningitis.
Powderly WG
Intern Med J; 2006 Jul; 36(7):404-5. PubMed ID: 16780444
[No Abstract] [Full Text] [Related]
57. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety.
Hamill RJ; Sobel JD; El-Sadr W; Johnson PC; Graybill JR; Javaly K; Barker DE
Clin Infect Dis; 2010 Jul; 51(2):225-32. PubMed ID: 20536366
[TBL] [Abstract][Full Text] [Related]
58. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.
Boulware DR; Meya DB; Muzoora C; Rolfes MA; Huppler Hullsiek K; Musubire A; Taseera K; Nabeta HW; Schutz C; Williams DA; Rajasingham R; Rhein J; Thienemann F; Lo MW; Nielsen K; Bergemann TL; Kambugu A; Manabe YC; Janoff EN; Bohjanen PR; Meintjes G;
N Engl J Med; 2014 Jun; 370(26):2487-98. PubMed ID: 24963568
[TBL] [Abstract][Full Text] [Related]
59. Short-Course Rather Than Low-Dose Amphotericin B May Exert Potential Influence on Mortality in Cryptococcal Meningitis Patients Treated With Amphotericin B Plus Flucytosine Alone or in Combination With Fluconazole.
Xu L; Tao R; Wu J; Dai X; Hu C; Huang Y; Chen Y; Zhu B; He J
Front Microbiol; 2019; 10():2082. PubMed ID: 31551999
[TBL] [Abstract][Full Text] [Related]
60. Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis.
Shiri T; Loyse A; Mwenge L; Chen T; Lakhi S; Chanda D; Mwaba P; Molloy SF; Heyderman RS; Kanyama C; Hosseinipour MC; Kouanfack C; Temfack E; Mfinanga S; Kivuyo S; Chan AK; Jarvis JN; Lortholary O; Jaffar S; Niessen LW; Harrison TS
Clin Infect Dis; 2020 Jan; 70(1):26-29. PubMed ID: 30816418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
